✦ LIBER ✦

Re: Insulinlike growth factor 1 receptor: predictive factor in breast cancer patients treated with trastuzumab?

✍ Scribed by Chikako Shimizu; Tadashi Hasegawa; Yasuhiro Fujiwara

Book ID: 116533917
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 41 KB
Volume: 36
Category: Article
ISSN: 1532-8392
DOI: 10.1016/j.humpath.2005.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulinlike growth factor-1 receptor: pr

Insulinlike growth factor-1 receptor: predictive factor in breast cancer patients treated with trastuzumab?

✍ Kadri Altundag; Ozden Altundag; Paolo Morandi; Bulent Ozcakar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Limited human epidermal growth factor re

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study

✍ van Rooijen, J.M.; de Munck, L.; de Graaf, J.C.; Siesling, S.; de Vries, E.G.; B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 384 KB

The level of HER2/neu gene amplification

The level of HER2/neu gene amplification as predictive factor in patients with metastatic breast cancer treated with a trastuzumab-based therapy

✍ G. Gullo; D. Bettio; V. Torri; G. Masci; P. Salvini; A. Santoro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Insulin-like growth factor receptor poly

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

✍ Winder, T; Giamas, G; Wilson, P M; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerge 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 403 KB

Co-expression of epidermal growth factor

Co-expression of epidermal growth factor receptor and transforming growth factor-α predicts worse prognosis in breast-cancer patients

✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Serum epidermal growth factor receptor/H

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer

✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a